Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about TAK

Recent news which mentions TAK

< Previous 1 2 3 4 5 6 7 8 Next >
Why Shares of Innate Pharma Jumped Thursday
Tickers IPHA SNY TAK
Tags TAK Recent Press Releases SNY
From Motley Fool
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Tickers ABBV JNJ TAK
Tags Briefs General Market News
From Benzinga
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
Tickers TAK TBPH TKPHF
Tags Trading Ideas TAK Benzinga
From Benzinga
Earnings Scheduled For May 11, 2023
Tickers RAIN RCEL REAX RGTI
Tags SCL SIEN SGBX
From Benzinga
Takeda's FY22 Net Profit Jumps 38%, But Expects Lower FY23 Revenues
Tickers TAK TKPHF
Tags Biotech Benzinga TAK
From Benzinga
Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More
Tickers CBD KHRNF MRMD PEP
Tags Open Book Extracts Markets MRMD
From Benzinga
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday
Tickers AMGN ARWR GSK TAK
Tags ARWR Market News TAK
From Motley Fool
This Supercharged Dividend King Stock Might Soon Run Out of Steam
Tickers ABBV ABT BMY GILD
Tags GILD ABBV TAK
From Motley Fool
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
Tickers GSK MRK SNY TAK
Tags TAK Media Government
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Tickers AGFY AMC BNRG CLEU
Tags TAK HSCS FNCH
From InvestorPlace
Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
Tickers AVAV AXP DHR ETSY
Tags AVAV DHR STEM
From Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
Tickers BMY TAK TKPHF
Tags Biotech Benzinga TAK
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Tickers ALG BBLN CHH DINO
Tags TAK KZR ESPR
From Benzinga
Johnson & Johnson's Experimental Dengue Pill Shows Efficacy In Animal Studies
Tickers JNJ TAK
Tags JNJ Benzinga Biotech
From Benzinga
Should You Give Up on Novavax?
Tickers MRNA NVAX PFE TAK
Tags Recent Press Releases NVAX PFE
From Motley Fool
2 Incredibly Cheap High-Yield Dividend Stocks to Buy Now
Tickers F TAK
Tags Market News F TAK
From Motley Fool
Takeda Presents Vedolizumab Data For Preventing Graft-Versus-Host Disease In Stem Cell Transplant Patients
Tickers TAK TKPHF
Tags Market News Health Care News
From Benzinga
Is This the Telltale Sign to Sell Novavax Stock?
Tickers MRNA NVAX PFE TAK
Tags Market News TAK MRNA
From Motley Fool
Takeda Reports 13% Fall In Nine Month Operating Profit, Keeps Annual Guidance Unchanged
Tickers TAK TKPHF
Tags Guidance Eurasia Large Cap
From Benzinga
7 Sorry Dividend Stocks to Sell in February Before It’s Too Late
Tickers BIG CPB CWH D
Tags MO INTC CPB
From InvestorPlace
Finch Therapeutics Halts Work On Its Only Clinical Stage Asset, Cuts 95% Of Workforce
Tickers FNCH TAK
Tags General FNCH Biotech
From Benzinga
HUTCHMED Out Licenses Fruquintinib To Takeda Outside China
Tickers HCM TAK
Tags TAK Trading Ideas Eurasia
From Benzinga
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
Tickers ARWR TAK TKPHF
Tags General TKPHF Briefs
From Benzinga
A Bullish Sign Appears On Takeda Pharmaceutical's Chart
Tickers TAK
Tags BZI/CROSS Trading Ideas TAK
From Benzinga
Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies
Tickers DCPH PFE TAK THRX
Tags News Initiation Health Care
From Benzinga
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
Tickers TAK TKPHF
Tags News Health Care Market News
From Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Tickers EXEL IPSEY RHHBY TAK
Tags Briefs General EXEL
From Benzinga
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
Tickers AMZN ARE BMY LLY
Tags META SAP UBER
From Motley Fool
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
Tickers TAK TKPHF
Tags Briefs Market News Benzinga
From Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
Tickers ACET BMY IPSC TAK
Tags TCBP BMY TAK
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.